Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SLC22A1 | O15245 | 3/20 | 1.00 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.93 |
| ▸ | TP53 | P04637 | 1/20 | 0.93 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.93 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.93 |
| ▸ | TSHR | P16473 | 1/20 | 0.93 |
| ▸ | ALOX12 | P18054 | 1/20 | 0.93 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.93 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.93 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.93 |
| ▸ | SLC22A2 | O15244 | 1/20 | 0.92 |
| ▸ | DNM1 | Q05193 | 6/20 | 0.81 |
| ▸ | HTT | P42858 | 1/20 | 0.65 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL5296604 | 1.00 | SLC22A1 (1.00) | SLC22A1ALDH1A1TP53CYP3A4ALOX15 | |
| SCHEMBL5306145 | 1.00 | SLC22A1 (1.00) | SLC22A1ALDH1A1TP53CYP3A4ALOX15 | |
| SCHEMBL5296135 | 1.00 | SLC22A1 (1.00) | SLC22A1ALDH1A1TP53CYP3A4ALOX15 | |
| SCHEMBL2872711 | 1.00 | SLC22A1 (1.00) | SLC22A1ALDH1A1TP53CYP3A4ALOX15 | |
| SCHEMBL5291412 | 1.00 | SLC22A1 (1.00) | SLC22A1ALDH1A1TP53CYP3A4ALOX15 | |
| SCHEMBL5287942 | 1.00 | SLC22A1 (1.00) | SLC22A1ALDH1A1TP53CYP3A4ALOX15 | |
| SCHEMBL5296028 | 1.00 | SLC22A1 (1.00) | SLC22A1ALDH1A1TP53CYP3A4ALOX15 | |
| SCHEMBL5293588 | 1.00 | SLC22A1 (1.00) | SLC22A1ALDH1A1TP53CYP3A4ALOX15 | |
| SCHEMBL22806629 | 1.00 | SLC22A1 (1.00) | SLC22A1ALDH1A1TP53CYP3A4ALOX15 | |
| SCHEMBL5293579 | 1.00 | SLC22A1 (1.00) | SLC22A1ALDH1A1TP53CYP3A4ALOX15 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 16 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2067770-B1 | PROCESS FOR PRODUCTION OF SULFONIC ACID ESTER | WAKO PURE CHEM IND LTD (JP) | 2017-04-12 | — | — | EP | disclosed |
| EP-2602856-B1 | NONAQUEOUS ELECTROLYTE SOLUTION AND NONAQUEOUS ELECTROLYTE BATTERY USING SAME | WAKO PURE CHEM IND LTD (JP) | 2017-02-22 | — | — | EP | disclosed |
| US-9257720-B2 | Nonaqueous electrolyte solution and nonaqueous electrolyte battery using same | WAKO PURE CHEMICAL INDUSTRIES, LTD. (JP) | 2016-02-09 | — | — | US | disclosed |
| US-9190695-B2 | Nonaqueous electrolyte solution, method for producing same, and nonaqueous electrolyte battery using the electrolyte solution | WAKO PURE CHEMICAL INDUSTRIES, LTD. (JP) | 2015-11-17 | — | — | US | disclosed |
| EP-2602855-B1 | NONAQUEOUS ELECTROLYTE SOLUTION, METHOD FOR PRODUCING SAME, AND NONAQUEOUS ELECTROLYTE BATTERY USING THE ELECTROLYTE SOLUTION | WAKO PURE CHEM IND LTD (JP) | 2015-02-18 | — | — | EP | disclosed |
| US-8546609-B2 | Ionic liquid containing allylsulfonate anion | WAKO PURE CHEMICAL INDUSTRIES, LTD. (JP) | 2013-10-01 | — | — | US | disclosed |
| EP-2602856-A1 | NONAQUEOUS ELECTROLYTE SOLUTION AND NONAQUEOUS ELECTROLYTE BATTERY USING SAME | Wako Pure Chemical Industries, Ltd. (JP) | 2013-06-12 | — | — | EP | disclosed |
| EP-2602855-A1 | NONAQUEOUS ELECTROLYTE SOLUTION, METHOD FOR PRODUCING SAME, AND NONAQUEOUS ELECTROLYTE BATTERY USING THE ELECTROLYTE SOLUTION | Wako Pure Chemical Industries, Ltd. (JP) | 2013-06-12 | — | — | EP | disclosed |
| US-20130143129-A1 | NONAQUEOUS ELECTROLYTE SOLUTION, METHOD FOR PRODUCING SAME, AND NONAQUEOUS ELECTROLYTE BATTERY USING THE ELECTROLYTE SOLUTION | WAKO PURE CHEMICAL INDUSTRIES, LTD. (JP) | 2013-06-06 | — | — | US | disclosed |
| US-20130130128-A1 | NONAQUEOUS ELECTROLYTE SOLUTION AND NONAQUEOUS ELECTROLYTE BATTERY USING SAME | WAKO PURE CHEMICAL INDUSTRIES, LTD. (JP) | 2013-05-23 | — | — | US | disclosed |
| US-8269038-B2 | Process for production of sulfonic acid ester | WAKO PURE CHEMICAL INDUSTRIES, LTD. (JP) | 2012-09-18 | — | — | US | disclosed |
| EP-2474527-A1 | IONIC LIQUID CONTAINING ALLYLSULFONATE ANION | Wako Pure Chemical Industries, Ltd. (JP) | 2012-07-11 | — | — | EP | disclosed |
| US-20120157680-A1 | IONIC LIQUID CONTAINING ALLYLSULFONATE ANION | WAKO PURE CHEMICAL INDUSTRIES, LTD. (JP) | 2012-06-21 | — | — | US | disclosed |
| US-20100041916-A1 | PROCESS FOR PRODUCTION OF SULFONIC ACID ESTER | WAKO PURE CHEMICAL INDUSTRIES, LTD. (JP) | 2010-02-18 | — | — | US | disclosed |
| EP-2067770-A1 | PROCESS FOR PRODUCTION OF SULFONIC ACID ESTER | Wako Pure Chemical Industries, Ltd. (JP) | 2009-06-10 | — | — | EP | disclosed |
| WO-2006131234-A1 | COSMETIC COMPOSITIONS COMPRISING IONIC LIQUIDS | HENKEL KOMMANDITGESELLSCHAFT AUF AKTIEN (DE) | 2006-12-14 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100041916-A1 | PROCESS FOR PRODUCTION OF SULFONIC ACID ESTER | SULT1A1, SULT2A1, STS | SLC22A1 983/4885ALDH1A1 90/4885TP53 4469/4885 |
| US-20120157680-A1 | IONIC LIQUID CONTAINING ALLYLSULFONATE ANION | ATXN2L, ARL1, INPPL1 | SLC22A1 1635/4885ALDH1A1 3717/4885TP53 3461/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.